References
- McEwen BS. Clinical review 108: The molecular and neuroanatomical basis for estrogen effects in the central nervous system. J UM Endocrinol Metab 1999;84:1790–7
- Koenig JI. Estrogen and brain function. Trends Endocrinol Metab 2001;12:4–6
- Xu H, Gouras GK, Greenfield JP, et al. Oestrogen reduces neuronal generation of Alzheimer [3 amyloid peptides. Nat Med 1998;4:447–51
- Sano M. Understanding the role of estrogen on cognition and dementia [Review]. J Neural Transm Suppl 2000;59:223–9
- Berman KF, Schmidt II, Rubinow DR, et al. Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomo-graphy study in women. Proc Natl Acad Sci USA 1997;94:8836–41
- Salat DH. Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. Arch Neuro/ 1999;56:338–44
- Takeda SMT. Age-related brain atrophy: a study with computed tomography. J Gerontol 1985; 40:159–63
- Murphy DG, DeCarli C, McIntosh AR, et al. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomo-graphy study on the effect of aging. Arch Gen Psychiatry 1996;53:585–94
- Zhang MY, Katzman R, Salmon D, et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990;27: 428–37
- Jorm AF, Korten AE, Henderson AS. The preva-lence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76: 465–79
- Henderson S. Epidemiology of dementia. Ann Med Interne (Paris) 1998;149:181–6
- Seshadri S, Zornberg GL, Derby LE, Myers MW, Jick H, Drachman DA. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch Neurol 2001;58:435–40
- Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA. Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol 2001;153:132–6
- Robertson DM, van Amelsvoort T, Daly E, et al. Effects of estrogen replacement therapy on human brain aging: an in vivo MRS study. Neurology 2001;57:2114–17
- Eberling JL, Reed BR, Coleman JE, Jagust WJ. Effect of estrogen on cerebral glucose metabolism in postmenopausal women. Neurology 2000;55: 875–7
- Greene RA. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease. Int J Fertil Women's Med 2000;45: 253–7
- Shaywitz SE, Shaywitz BA, Pugh KR, et al. Effect of estrogen on brain activation patterns in post-menopausal women during working memory tasks. J Am Med Assoc 1999;281:1197–202
- Smith YR, Minoshima S, Kuhl DE, Zubieta JK. Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J Clin Endocrinol Metab 2001;86:679–84
- Travis M, Mulligan O, Mulligan R, et al. Preliminary investigation of the effect of oestradiol treatment on cortical 5-HT receptor binding — a single photon emission tomography (SPET) study using I-5-I-R91150. Neuroimage 1999;6:S672
- Moses EL, Drevets WC, Smith G, et al. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol Psychiatry 2000;48:854–60
- Maki PM, Resnick SM. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 2000;21:373–83
- Rasgon NL, Small GW, Siddarth P, et al. Estrogen use and brain metabolic change in older adults. A preliminary report. Psychiatry Res Neuroimag Sect 2001;107:11–18
- Toran-Allerand CD. Estrogen as a treatment for Alzheimer disease [Letter]. J Am Med Assoc 2000;284:307–8
- Shumaker SA, Reboussin BA, Espeland MA, et al. The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the pro-gression of dementia. Control Clin Trials 1998; 19:604–21
- Halbreich U, Kahn LS. Selective oestrogen recep-tor modulators — current and future brain and behaviour applications [Review]. Expert Opin Pharmacother 2000;1:1385–98
- Xin Wu. Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltrans-ferase activity in ovariectomized rats. Brain Res 1999;847:98–104
- Thomas T, Bryant M, Clark L, Garces A, Rhodin J. Estrogen and raloxifene activities on amyloid-P-induced inflammatory reaction. Microvasc Res 2001;61:28–39
- Neele SJ, Rombouts SA, Bierlaagh MA, Barkhof F, Scheltens P, Netelenbos JC. Raloxifene affects brain activation patterns in postmenopausal women during visual encoding. J Clin Endocrinol Metab 2001;86:1422–4
- Yaffe K, Krueger K, Sarkar S, et al. Cognitive function in postmenopausal women treated with raloxifene [see Comments]. N Engl J Med 2001; 344:1207–13